Q1 Earnings Estimate for Medifast Issued By DA Davidson

Medifast, Inc. (NYSE:MED) – Investment analysts at DA Davidson issued their Q1 2025 EPS estimates for Medifast in a report released on Thursday, February 20th. DA Davidson analyst L. Weiser expects that the specialty retailer will earn ($0.32) per share for the quarter. DA Davidson currently has a “Neutral” rating and a $16.50 price target on the stock. The consensus estimate for Medifast’s current full-year earnings is $0.51 per share. DA Davidson also issued estimates for Medifast’s FY2026 earnings at $0.50 EPS.

Medifast (NYSE:MED) last issued its earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.26. Medifast had a net margin of 0.35% and a return on equity of 10.64%. The firm had revenue of $119.00 million during the quarter, compared to analyst estimates of $114.25 million.

Medifast Stock Performance

Shares of NYSE:MED opened at $14.79 on Monday. The firm has a fifty day moving average price of $16.09 and a 200 day moving average price of $17.86. Medifast has a fifty-two week low of $13.57 and a fifty-two week high of $42.68. The firm has a market cap of $161.78 million, a price-to-earnings ratio of 82.17 and a beta of 1.14.

Hedge Funds Weigh In On Medifast

Several institutional investors have recently bought and sold shares of the business. Two Sigma Advisers LP lifted its position in Medifast by 86.0% during the fourth quarter. Two Sigma Advisers LP now owns 216,000 shares of the specialty retailer’s stock valued at $3,806,000 after purchasing an additional 99,900 shares during the last quarter. Two Sigma Investments LP lifted its position in Medifast by 11.4% during the fourth quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer’s stock valued at $4,089,000 after purchasing an additional 23,822 shares during the last quarter. State of Wyoming lifted its position in Medifast by 286.1% during the fourth quarter. State of Wyoming now owns 11,312 shares of the specialty retailer’s stock valued at $199,000 after purchasing an additional 8,382 shares during the last quarter. Deutsche Bank AG lifted its position in Medifast by 10.4% during the fourth quarter. Deutsche Bank AG now owns 29,553 shares of the specialty retailer’s stock valued at $521,000 after purchasing an additional 2,787 shares during the last quarter. Finally, Bridgeway Capital Management LLC bought a new position in Medifast during the fourth quarter valued at $352,000. Institutional investors own 95.51% of the company’s stock.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.